Author

Soonpin Yei

Observed names: S P Yei, S Yei, S. YEI, SOONPIN YEI, Soon-pin Yei

Institution: Sorrento Therapeutics (United States)

Observed institutions: Cedars-Sinai Medical Center, Center for Biologics Evaluation and Research, United States Food and Drug Administration, Emory University, University of California, Los Angeles, Institut thématique Immunologie, inflammation, infectiologie et microbiologie, Sorrento Therapeutics (United States), Richard L. Roudebush VA Medical Center, Saint Louis University, Case Western Reserve University, The University of Texas Health Science Center at Houston

OpenAlex ID: A5111507153

Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice

1993 · Theodore A. G. Smith, Michele G. Mehaffey, et al. · Nature Genetics · 336

Elimination of both E1 and E2 from adenovirus vectors further improves prospects for in vivo human gene therapy

1996 · M I Gorziglia, M J Kadan, et al. · Journal of Virology · 193

Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung.

1994 · S Yei, N Mittereder, et al. · PubMed · 189

In Vivo Evaluation of the Safety of Adenovirus-Mediated Transfer of the Human Cystic Fibrosis Transmembrane Conductance Regulator cDNA to the Lung

1994 · Soonpin Yei, Nanette Mittereder, et al. · Human Gene Therapy · 172

Persistence of Replication-Deficient Adenovirus-Mediated Gene Transfer in Lungs of Immune-Deficient (nu/nu) Mice

1995 · Zsuzsanna K. Zsengeller, Susan E. Wert, et al. · Human Gene Therapy · 148

The E1B 19,000-molecular-weight protein of group C adenoviruses prevents tumor necrosis factor cytolysis of human cells but not of mouse cells

1991 · L R Gooding, L Aquino, et al. · Journal of Virology · 137

The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus form a complex and function together to down-regulate the epidermal growth factor receptor

1991 · A E Tollefson, A R Stewart, et al. · Journal of Virology · 94

Partitioning of hepatitis C virus during Cohn‐Oncley fractionation of plasma

1992 · S. YEI, M.W. Yu, et al. · Transfusion · 87

Safety of Adenovirus-Mediated Transfer of the Human Cystic Fibrosis Transmembrane Conductance Regulator cDNA to the Lungs of Nonhuman Primates

1996 · Robert W. Wilmott, Raouf S. Amin, et al. · Human Gene Therapy · 74

Evaluation of the Efficacy and Safety of In Vitro , Adenovirus-Mediated Transfer of the Human Cystic Fibrosis Transmembrane Conductance Regulator cDNA

1994 · Nanette Mittereder, Soonpin Yei, et al. · Human Gene Therapy · 74

Intracellular application of hairpin ribozyme genes against hepatitis B virus

1997 · PJ Welch, R Tritz, et al. · Gene Therapy · 71

A potential therapeutic application of hairpin ribozymes: in vitro and in vivo studies of gene therapy for hepatitis C virus infection.

1996 · P J Welch, R Tritz, et al. · PubMed · 71

A 10,400-molecular-weight membrane protein is coded by region E3 of adenovirus

1990 · A E Tollefson, P Krajcsi, et al. · Journal of Virology · 54

PDF

The adenovirus E3 10.4K and 14.5K proteins, which function to prevent cytolysis by tumor necrosis factor and to down-regulate the epidermal growth factor receptor, are localized in the plasma membrane

1995 · A R Stewart, A E Tollefson, et al. · Journal of Virology · 53

Chimeric DNA-RNA Hammerhead Ribozyme to Proliferating Cell Nuclear Antigen Reduces Stent-Induced Stenosis in a Porcine Coronary Model

1999 · Aaron Frimerman, Peter J. Welch, et al. · Circulation · 52

PDF

Adenoviral-Mediated Gene Transfer of Human Surfactant Protein B to Respiratory Epithelial Cells

1994 · S Yei, C J Bachurski, et al. · American Journal of Respiratory Cell and Molecular Biology · 52

Ribozyme gene therapy for hepatitis C virus infection

1998 · Peter J Welch, Soonpin Yei, et al. · Clinical and Diagnostic Virology · 45

Characterization of the adenovirus E3 protein that down-regulates the epidermal growth factor receptor. Evidence for intermolecular disulfide bonding and plasma membrane localization.

1992 · P Hoffman, M.B. Yaffe, et al. · Journal of Biological Chemistry · 41

Novel membrane-bound GM-CSF vaccines for the treatment of cancer: generation and evaluation of mbGM-CSF mouse B16F10 melanoma cell vaccine

2002 · S Yei, R M Bartholomew, et al. · Gene Therapy · 31

Identification and characterization of the herpes simplex virus type 2 gene encoding the essential capsid protein ICP32/VP19c

1990 · S P Yei, S I Chowdhury, et al. · Journal of Virology · 13

Distinct Domains in the Adenovirus E3 RIDα Protein Are Required for Degradation of Fas and the Epidermal Growth Factor Receptor

2003 · Tom A. Zanardi, Soonpin Yei, et al. · Journal of Virology · 12

Surfactant Effects on Aerosolized and Instilled Adenoviral-Mediated Gene Transfer

1996 · Alan H. Jobe, Machiko Ikegami, et al. · Human Gene Therapy · 12

Interference by a Non-Interferon-Inducing Subvariant of Benign Encephalomyocarditis Virus-B with the Ability of EMCV-D to Produce Insulin-Dependent Diabetes Mellitus in ICR Swiss Male Mice

1993 · DAVID J. GIRON, SOONPIN YEI · Journal of Interferon Research · 6

Detection and Quantitation of HCV-RNA in Immune Globulins Produced by Cohn-Oncley Fractionation of Human Plasma

1994 · Mei-ying W. Yu, Bobby L. Mason, et al. · Springer eBooks · 3

A Targeted Vaccine against COVID-19: S1-Fc Vaccine Targeting the Antigen-Presenting Cell Compartment Elicits Protection against SARS-CoV-2 Infection

2020 · Andreas Herrmann, Junki Maruyama, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2

PDF

Works count: 33

Citation count: 2,024

H-index: 19

I10-index: 22